$AIXN
AiXin Life International, Inc. Stock $aixn

$aixn Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223040930 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$792.1K	$1.067M	$672.8K
YoY Change	-33.78%	58.58%	-17.24%
Cost Of Revenue	$900.6K	$960.0K	$619.7K
YoY Change	-11.28%	54.91%	37.33%
Gross Profit	-$108.5K	$110.0K	$53.08K
YoY Change	-159.93%	107.23%	-85.32%
Gross Profit Margin	-13.7%	10.31%	7.89%
Selling, General & Admin	$998.3K	$710.5K	$426.5K
YoY Change	41.56%	66.61%	-6.31%
% of Gross Profit		645.95%	803.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$100.7K	$114.3K	$25.70K
YoY Change	-1.91%	344.75%	132.79%
% of Gross Profit		103.91%	48.42%
Operating Expenses	$998.3K	$1.802M	$1.207M
YoY Change	41.56%	49.35%	165.1%
Operating Profit	-$1.107M	-$735.3K	-$533.9K
YoY Change	111.16%	37.71%	470.96%
Interest Expense	$150.00	$0.00	$1.020K
YoY Change	-87.9%	-100.0%	70.0%
% of Operating Profit
Other Income/Expense, Net	$95.10K	$297.6K	-$3.840M
YoY Change	1090.24%	-107.75%	-18472.87%
Pretax Income	-$1.012M	-$437.6K	-$4.374M
YoY Change	96.45%	-89.99%	5973.92%
Income Tax	$13.64K	$515.00	-$322.00
% Of Pretax Income
Net Earnings	-$1.025M	-$438.2K	-$4.374M
YoY Change	98.92%	-89.98%	2893.51%
Net Earnings / Revenue	-129.43%	-41.07%	-650.06%
Basic Earnings Per Share		-$0.02	-$0.09
Diluted Earnings Per Share	-$0.04	-$0.02	-$87.47K
COMMON SHARES
Basic Shares Outstanding	25.00M shares	25.00M shares	50.00M shares
Diluted Shares Outstanding		25.00M shares	25.00M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$443.8K	$410.0K	$5.299M
YoY Change	-13.01%	-92.26%	60.67%
Cash & Equivalents	$443.8K	$412.7K	$5.299M
Short-Term Investments
Other Short-Term Assets	$173.0K	$590.0K	$295.1K
YoY Change	-19.05%	99.94%	-0.09%
Inventory	$441.1K	$643.6K	$857.8K
Prepaid Expenses
Receivables	$253.6K	$250.6K	$196.4K
Other Receivables	$12.40K	$30.00K	$25.56K
Total Short-Term Assets	$1.497M	$2.065M	$6.826M
YoY Change	-24.22%	-69.75%	64.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.680M	$1.659M	$1.911M
YoY Change	-14.81%	-13.18%	-20.7%
Goodwill			$3.824M
YoY Change
Intangibles	$3.917K	$2.840K	$1.393K
YoY Change	208.67%	103.88%
Long-Term Investments	$84.51K	$80.00K	$84.35K
YoY Change	-2.85%	-5.16%	-9.42%
Other Assets	$0.00	$10.00K	$15.52K
YoY Change	-100.0%	-35.57%
Total Long-Term Assets	$3.345M	$2.215M	$3.186M
YoY Change	8.78%	-30.47%	27.16%
TOTAL ASSETS
Total Short-Term Assets	$1.497M	$2.065M	$6.826M
Total Long-Term Assets	$3.345M	$2.215M	$3.186M
Total Assets	$4.842M	$4.280M	$10.01M
YoY Change	-4.13%	-57.25%	50.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$478.5K	$600.0K	$508.0K
YoY Change	20.07%	18.11%	18.58%
Accrued Expenses	$2.927M	$2.530M	$6.616M
YoY Change	-7.27%	-61.76%	318.92%
Deferred Revenue
YoY Change
Short-Term Debt	$84.51K	$80.00K	$84.35K
YoY Change	-2.85%	-5.16%	-81.79%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.964M	$5.067M	$9.287M
YoY Change	12.06%	-45.44%	178.12%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$789.5K	$160.0K	$382.2K
YoY Change	305.43%	-58.13%	-68.31%
Total Long-Term Liabilities	$789.5K	$160.0K	$382.2K
YoY Change	305.43%	-58.13%	-68.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.964M	$5.067M	$9.287M
Total Long-Term Liabilities	$789.5K	$160.0K	$382.2K
Total Liabilities	$6.754M	$5.225M	$9.669M
YoY Change	22.42%	-45.96%	112.74%
SHAREHOLDERS EQUITY
Retained Earnings	-$17.22M	-$16.20M	-$14.73M
YoY Change	12.92%	9.91%
Common Stock	$250.00	$250.00	$500.00
YoY Change	0.0%	-50.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.912M	-$945.1K	$342.1K
YoY Change
Total Liabilities & Shareholders Equity	$4.842M	$4.280M	$10.01M
YoY Change	-4.13%	-57.25%	50.21%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$1.025M	-$438.2K	-$4.374M
YoY Change	98.92%	-89.98%	2893.51%
Depreciation, Depletion And Amortization	$100.7K	$114.3K	$25.70K
YoY Change	-1.91%	344.75%	132.79%
Cash From Operating Activities	-$1.172M	$130.0K	-$641.1K
YoY Change	452.9%	-120.28%	-703.23%
INVESTING ACTIVITIES
Capital Expenditures	$79.52K	$210.0K	-$52.49K
YoY Change	-23.71%	-500.08%
Acquisitions
YoY Change
Other Investing Activities	-$3.320K	$0.00	$446.4K
YoY Change	-99.91%	-100.0%	428.57%
Cash From Investing Activities	-$82.84K	-$200.0K	$393.9K
YoY Change	-97.88%	-150.77%	366.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.210M	170.0K	-2.305M
YoY Change	-240.14%	-107.38%	1456.72%
NET CHANGE
Cash From Operating Activities	-1.172M	130.0K	-641.1K
Cash From Investing Activities	-82.84K	-200.0K	393.9K
Cash From Financing Activities	1.210M	170.0K	-2.305M
Net Change In Cash	-44.63K	100.0K	-2.552M
YoY Change	-99.11%	-103.92%	-6082.26%
FREE CASH FLOW
Cash From Operating Activities	-$1.172M	$130.0K	-$641.1K
Capital Expenditures	$79.52K	$210.0K	-$52.49K
Free Cash Flow	-$1.252M	-$80.00K	-$588.6K
YoY Change	295.82%	-86.41%	-653.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0000835662
CY2023Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2022Q3	AIXN	Government Grant Income GovernmentGrantIncome		usd
	AIXN	Government Grant Income GovernmentGrantIncome		usd
	AIXN	Inventory Impairment InventoryImpairment		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	AIXN	Government Grant Income GovernmentGrantIncome		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	AIXN	Cash Disposed At Disposal Of Subsidiary CashDisposedAtDisposalOfSubsidiary		usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		usd
	AIXN	Proceeds From Government Grant ProceedsFromGovernmentGrant		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	AIXN	Accrual Of Unpaid Investment In Subsidiary AccrualOfUnpaidInvestmentInSubsidiary		usd
	us-gaap	Transfer To Investments TransferToInvestments		usd
	AIXN	Acquisition Of Subsidiary AcquisitionOfSubsidiary		usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries		usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-17284
	dei	Entity Registrant Name EntityRegistrantName	AIXIN LIFE INTERNATIONAL, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1085935
	dei	Entity Address Address Line1 EntityAddressAddressLine1	Hongxing International Business Building 2, 14th FL
	dei	Entity Address Address Line2 EntityAddressAddressLine2	No. 69 Qingyun South Ave.
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Jinjiang District
	dei	Entity Address City Or Town EntityAddressCityOrTown	Chengdu City
	dei	Entity Address Country EntityAddressCountry	CN
	dei	City Area Code CityAreaCode	86
	dei	Local Phone Number LocalPhoneNumber	313-6732526
	dei	Security12b Title Security12bTitle	Common Stock, $0.00001 Par Value
	dei	Trading Symbol TradingSymbol	AIXN
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24999842	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	412659	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	510128	usd
CY2023Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	85676	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	109772	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	250561	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	562581	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	143324	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	42631	usd
CY2023Q3	us-gaap	Supplies Supplies	144613	usd
CY2022Q4	us-gaap	Supplies Supplies	168523	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	643623	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	499252	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	2065044	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1975989	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1658885	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1971793	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2840	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1269	usd
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	13278	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	15556	usd
CY2023Q3	us-gaap	Security Deposit SecurityDeposit	82237	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	86992	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	457793	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	999285	usd
CY2023Q3	us-gaap	Assets Assets	4280077	usd
CY2022Q4	us-gaap	Assets Assets	5050884	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	466804	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	139502	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	110246	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	104100	usd
CY2023Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	2136132	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	2356490	usd
CY2023Q3	AIXN	Government Grant GovernmentGrant	898424	usd
CY2022Q4	AIXN	Government Grant GovernmentGrant	950371	usd
CY2023Q3	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	82237	usd
CY2022Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	86992	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	439959	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	883583	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5067094	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5322347	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	158069	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	194725	usd
CY2023Q3	us-gaap	Liabilities Liabilities	5225163	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5517072	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24999842	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24999842	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24999842	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24999842	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	250	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	250	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14882538	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14458583	usd
CY2023Q3	AIXN	Statutory Reserves StatutoryReserves	151988	usd
CY2022Q4	AIXN	Statutory Reserves StatutoryReserves	151988	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16195184	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15249858	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	215322	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	172849	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-945086	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-466188	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4280077	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5050884	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1066919	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	672786	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3297689	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1512351	usd
CY2023Q3	AIXN	Cost Of Goods And Service Sold CostOfGoodsAndServiceSold	509723	usd
CY2022Q3	AIXN	Cost Of Goods And Service Sold CostOfGoodsAndServiceSold	215383	usd
	AIXN	Cost Of Goods And Service Sold CostOfGoodsAndServiceSold	1136411	usd
	AIXN	Cost Of Goods And Service Sold CostOfGoodsAndServiceSold	493905	usd
CY2023Q3	AIXN	Hotel Operating Costs HotelOperatingCosts	447419	usd
CY2022Q3	AIXN	Hotel Operating Costs HotelOperatingCosts	404322	usd
	AIXN	Hotel Operating Costs HotelOperatingCosts	1387993	usd
	AIXN	Hotel Operating Costs HotelOperatingCosts	1334041	usd
CY2023Q3	us-gaap	Selling Expense SellingExpense	210906	usd
CY2022Q3	us-gaap	Selling Expense SellingExpense	193820	usd
	us-gaap	Selling Expense SellingExpense	628754	usd
	us-gaap	Selling Expense SellingExpense	583438	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	499638	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	232642	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1268119	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	752113	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	41603	usd
CY2022Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	67638	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-10250	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	115495	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	92885	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	92885	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	278655	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	278655	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1802174	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	1206690	usd
	us-gaap	Operating Expenses OperatingExpenses	4689682	usd
	us-gaap	Operating Expenses OperatingExpenses	3557647	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-735255	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-533904	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1391993	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2045296	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	135	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1024	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	692	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	3636	usd
CY2022Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3823770	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3823770	usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	13293	usd
CY2022Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	12134	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	52395	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	41789	usd
CY2023Q3	AIXN	Government Grant Income GovernmentGrantIncome	284321	usd
	AIXN	Government Grant Income GovernmentGrantIncome	284321	usd
CY2023Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	135	usd
CY2022Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	29317	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	5022	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	29577	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	297614	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3839929	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	332386	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3807922	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-437641	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4373833	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1059607	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5853218	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	515	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-322	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5879	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	643	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-438156	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4373511	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1065486	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5853861	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	16086	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-139053	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	42473	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-152137	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-422070	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4512564	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1023013	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6005998	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.018
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.018
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.175
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.175
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.043
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.043
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.234
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.234
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24999842	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24999842	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24999842	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24999842	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24999842	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24999842	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24999842	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24999842	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-466188	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	92885	usd
CY2023Q1	AIXN	Disposal Of Subsidiary DisposalOfSubsidiary	120160	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-529784	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	24542	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-758385	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	92885	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	145300	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-97546	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1845	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-615901	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	92885	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-438156	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	16086	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-945086	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6069491	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	92885	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-752081	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	31864	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	5442159	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	92885	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-728269	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-44948	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4761827	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	92885	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4373511	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-139053	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	342148	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1065486	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5853861	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	308114	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	82921	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-10250	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	115495	usd
	AIXN	Inventory Impairment InventoryImpairment	8558	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	618085	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	632496	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	278655	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	278655	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1481	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1419	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3823770	usd
	AIXN	Government Grant Income GovernmentGrantIncome	284321	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	18596	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-100801	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	97872	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	186658	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	192791	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	347347	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-9444	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	12273	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-187009	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	500056	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	525979	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-136638	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	232910	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-219874	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1412550	usd
	AIXN	Cash Disposed At Disposal Of Subsidiary CashDisposedAtDisposalOfSubsidiary	-3341	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	446381	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	212607	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	52485	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2608	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-218556	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	393896	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-79072	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-1525860	usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	142200	usd
	AIXN	Proceeds From Government Grant ProceedsFromGovernmentGrant	284321	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	347449	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1525860	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-30584	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-677533	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-121565	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3222047	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	619900	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8600853	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	498335	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5378806	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4398	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	72495	usd
	AIXN	Accrual Of Unpaid Investment In Subsidiary AccrualOfUnpaidInvestmentInSubsidiary	3907139	usd
	us-gaap	Transfer To Investments TransferToInvestments	734290	usd
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 2 reverse stock split
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24999842	shares
CY2023Q3	us-gaap	Profit Loss ProfitLoss	438156	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	4373511	usd
	us-gaap	Profit Loss ProfitLoss	1065486	usd
	us-gaap	Profit Loss ProfitLoss	5853861	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-219874	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1412550	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16195184	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	510128	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	412659	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_843_eus-gaap--UseOfEstimates_zyJPFndUtHWh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span id="xdx_86F_zVK05osWAPI4">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In preparing consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Significant estimates required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zzI4n6HWe5j4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span id="xdx_867_zMARoRMvhaNb">Reclassification</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Certain prior period amounts have been reclassified to conform to the current period presentation and had no effect on previously reported consolidated net income (loss) or accumulated deficit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	247753	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	272550	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	272550	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	213787	usd
	AIXN	Reversal Of Provision For Bad Debts ReversalOfProvisionForBadDebts	62100	usd
	AIXN	Reversal Of Provision For Bad Debts ReversalOfProvisionForBadDebts	115495	usd
	AIXN	Acquisition Of Subsidiary AcquisitionOfSubsidiary	185561	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	72350	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	14547	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	31497	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	247753	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	483346	usd
CY2023Q3	AIXN	Provision For Inventory Reserve ProvisionForInventoryReserve	8558	usd
CY2022Q3	AIXN	Provision For Inventory Reserve ProvisionForInventoryReserve	0	usd
CY2023Q3	us-gaap	Property Plant And Equipment Salvage Value Percentage PropertyPlantAndEquipmentSalvageValuePercentage	0.05	pure
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3823770	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1066919	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zRnOUDheZLwg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span id="xdx_866_zDeKBqPNEIo4">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The operations of the Company are in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, and by the general state of the PRC economy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company has cash on hand and demand deposits in accounts maintained with state-owned banks within the PRC. Cash in state-owned banks is covered by insurance up to RMB <span id="xdx_904_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_uRMB_c20230930_zNc9TIaQ5yZ3">500,000</span> ($<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_uUSD_c20230930_zkl5oH6hQYga" title="Cash FDIC insured amount">72,500</span>) per bank. The Company has not experienced any losses in such accounts and believes they are not exposed to any risks on its cash in these bank accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During the three and nine months ended September 30, 2023 and 2022, the Company had no customer that accounted for over <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zXxJVUmJG3xi" title="Concentration risk percentage1"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zdRwJXVMXvQ5" title="Concentration risk percentage1"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zKYT4YtBhcUf" title="Concentration risk percentage1"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zzETQrcbYw13" title="Concentration risk percentage1">10</span></span></span></span>% of its total revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During the three months ended September 30, 2023, the Company had one supplier that accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierOneMember_zQICh4pK2j4d" title="Concentration risk, percentage">20</span>% of its total purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During the nine months ended September 30, 2023, the Company had two suppliers that accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierOneMember_zH2hXUsqYAIi" title="Concentration risk, percentage">15</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierTwoMember_zx2BZwj9uCQ8" title="Concentration risk, percentage">12</span>%, respectively, of its total purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During the three months ended September 30, 2022, the Company had one supplier that accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierOneMember_zFsKbHbFFqrb" title="Concentration risk, percentage">35</span>% of its total purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During the nine months ended September 30, 2022, the Company had one supplier that accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierOneMember_zK3LwnZeSCyf" title="Concentration risk, percentage">20</span>% of its total purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	500000
CY2023Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	72500	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	672786	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1802174	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1206690	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-735255	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-533904	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3297689	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1512351	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	4689682	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	3557647	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1391993	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2045296	usd
CY2023Q3	us-gaap	Assets Assets	4280077	usd
CY2022Q4	us-gaap	Assets Assets	5050884	usd
CY2023Q3	us-gaap	Deposit Assets DepositAssets	12245	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	15546	usd
CY2023Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	102704	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	9490	usd
CY2023Q3	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	7379	usd
CY2022Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	10124	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	20996	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	7471	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	143324	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	42631	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	573073	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	78034	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	73821	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	643623	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	499252	usd
CY2023Q3	us-gaap	Supplies Supplies	144613	usd
CY2022Q4	us-gaap	Supplies Supplies	168523	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	142519	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	62462	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	15265	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	15315	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	521	usd
CY2023Q3	AIXN	Drugs Pharmaceutical And Nutritional Products DrugsPharmaceuticalAndNutritionalProducts	486273	usd
CY2022Q4	AIXN	Drugs Pharmaceutical And Nutritional Products DrugsPharmaceuticalAndNutritionalProducts	412129	usd
CY2023Q3	AIXN	Inventory Food And Beverage Hotel Supplies And Consumables Gross InventoryFoodAndBeverageHotelSuppliesAndConsumablesGross	77600	usd
CY2022Q4	AIXN	Inventory Food And Beverage Hotel Supplies And Consumables Gross InventoryFoodAndBeverageHotelSuppliesAndConsumablesGross	82646	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	721657	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2859273	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2928342	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1200388	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	956549	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1658885	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1971793	usd
CY2023Q3	us-gaap	Depreciation Depreciation	114300	usd
CY2022Q3	us-gaap	Depreciation Depreciation	25111	usd
	us-gaap	Depreciation Depreciation	307209	usd
	us-gaap	Depreciation Depreciation	81036	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10609	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8564	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7769	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7295	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2840	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1269	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	387	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	591	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	905	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1885	usd
CY2023Q3	us-gaap	Accrued Rent Current AccruedRentCurrent	74415	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	110246	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	104100	usd
CY2023Q3	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	281728	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	270349	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	248759	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	307331	usd
CY2022Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	32746	usd
CY2023Q3	us-gaap	Construction Payable Current ConstructionPayableCurrent	1196037	usd
CY2022Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	1384674	usd
CY2023Q3	AIXN	Payable For Equipment Purchase Current PayableForEquipmentPurchaseCurrent	29213	usd
CY2022Q4	AIXN	Payable For Equipment Purchase Current PayableForEquipmentPurchaseCurrent	32278	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	247786	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	233894	usd
CY2023Q3	us-gaap	Deposit Liability Current DepositLiabilityCurrent	10690	usd
CY2022Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	11308	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	47504	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	83910	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2136132	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2356490	usd
CY2023Q3	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	82237	usd
CY2022Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	86992	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	457793	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	999285	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	439959	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	883583	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	158069	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	194725	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	598028	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1078308	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	200716	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	183051	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	618085	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	632496	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	500056	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	525979	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M3D
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M24D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	354246	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	130992	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	79844	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	36366	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8224	usd
CY2023Q3	AIXN	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	3427	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	613099	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	15071	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	598028	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	439959	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	158069	usd
CY2023Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	94361	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	333919	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	236882	usd
CY2014Q2	us-gaap	Payments For Rent PaymentsForRent	5000
CY2014Q2	us-gaap	Payments For Rent PaymentsForRent	690	usd
CY2014Q2	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2028-05-28
CY2023Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2020Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	one (1)-for-four (4) reverse stock.
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	24999842	shares
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	92885	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	92885	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	278655	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	278655	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	394012	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	394012	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y25D
	AIXN	Net Income Transfer Percentage NetIncomeTransferPercentage	0.10	pure
	AIXN	Capital Reserve Percentage CapitalReservePercentage	0.50	pure
CY2023Q3	AIXN	Statutory Reserve Fund StatutoryReserveFund	0	usd
CY2022Q3	AIXN	Statutory Reserve Fund StatutoryReserveFund	0	usd
	AIXN	Statutory Reserve Fund StatutoryReserveFund	0	usd
	AIXN	Statutory Reserve Fund StatutoryReserveFund	0	usd
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_80C_eus-gaap--LossContingencyDisclosures_zjR6Twx6Ttab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>16. <span id="xdx_823_zcdiuAsDpyma">OPERATING CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company’s operations in the PRC are subject to specific considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environments and foreign currency exchange. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company’s sales, purchases and expenses are denominated in RMB and all of the Company’s assets and liabilities are also denominated in RMB. The RMB is not freely convertible into foreign currencies under the current law. In China, foreign exchange transactions are required by law to be transacted only by authorized financial institutions. Remittances in currencies other than RMB may require certain supporting documentation to affect the remittance. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Litigation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company is, from time to time, involved in litigation incidental to the conduct of its business regarding merchandise sold, employment matters, and litigation regarding intellectual property rights.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In December 2020, Jian Yiao (the “Plaintiff”) filed a complaint against Chengdu Aixintang Pharmacy Co., Ltd. (“Aixintang Pharmacy”, or the “Defendant”) in Zhangjiagang People’s Court in Jiangsu Province. The complaint alleges that Jian Yiao is entitled to $<span id="xdx_900_eus-gaap--LongTermPurchaseCommitmentAmount_c20201201__20201231_zfWzdfoD5ulb" title="Purchase commitment amount">392,305</span> (RMB <span id="xdx_908_eus-gaap--LongTermPurchaseCommitmentAmount_uRMB_c20201201__20201231_zhejMdYkFpR2" title="Purchase commitment amount">2,500,000</span>) from Aixintang Pharmacy for not fulfilling the contractual obligation of a purchase agreement entered in March 2020 (the “Purchase Agreement”). Aixintang Pharmacy claimed that the Purchase Agreement was falsely entered by an employee through forged documents, and that Aixintang Pharmacy did not enter the Purchase Agreement. The Court determined that Aixintang Pharmacy breached the Purchase Agreement by not delivering the products ordered and ordered Aixintang Pharmacy to pay $<span id="xdx_909_eus-gaap--LitigationSettlementExpense_c20201201__20201231_zWvu4YGlkfkb" title="Litigation settlement expense">392,305</span> (RMB <span id="xdx_905_eus-gaap--LitigationSettlementExpense_uRMB_c20201201__20201231_zJ33G4KcztCf" title="Litigation settlement expense">2,500,000</span>) to the Plaintiff. In December 2020, Aixintang Pharmacy filed a motion in the Jiangsu Suzhou Intermediate People’s Court against the determination reached from the first trial.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In February 2021, the judge in the Jiangsu Suzhou Intermediate People’s Court denied the Defendant’s motion and upheld the judgment from the first trial. In March 2021, Aixintang Pharmacy filed another motion to the Jiangsu High People’s Court on the basis that the Purchase Agreement was forged. In February 2022, Aixintang Pharmacy filed an appeal in Jiangsu High People’s Court against the judgment reached by Jiangsu Suzhou Intermediate People’s Court in February 2021. To date, this legal proceeding remains pending.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In November 2021, the Company and Mr. Quanzhong Lin agreed that Mr. Lin shall assume any losses arising from this legal proceeding. As such, the Company did not accrue contingent losses from this legal proceeding as of September 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company believes that current pending litigation will not have a material adverse effect on its consolidated financial position, results of operations or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2020Q4	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	392305	usd
CY2020Q4	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	2500000
CY2020Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	392305	usd
CY2020Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	2500000
CY2023Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	804470	usd
CY2023Q3	AIXN	Business Acquisitions Pro Forma Cost Of Goods And Services Sold BusinessAcquisitionsProFormaCostOfGoodsAndServicesSold	-1205371	usd
CY2023Q3	AIXN	Business Acquisitions Pro Forma Loss From Operations BusinessAcquisitionsProFormaLossFromOperations	400901	usd
CY2023Q3	AIXN	Business Acquisitions Pro Forma Other Nonoperating Income Expense BusinessAcquisitionsProFormaOtherNonoperatingIncomeExpense	-25455	usd
CY2023Q3	AIXN	Business Acquisitions Pro Forma Income Tax Expense Benefit BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit	-322	usd
CY2023Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	426034	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1854617	usd
	AIXN	Business Acquisitions Pro Forma Cost Of Goods And Services Sold BusinessAcquisitionsProFormaCostOfGoodsAndServicesSold	-3826342	usd
	AIXN	Business Acquisitions Pro Forma Loss From Operations BusinessAcquisitionsProFormaLossFromOperations	1971725	usd
	AIXN	Business Acquisitions Pro Forma Other Nonoperating Income Expense BusinessAcquisitionsProFormaOtherNonoperatingIncomeExpense	25313	usd
	AIXN	Business Acquisitions Pro Forma Other Nonoperating Income Expense BusinessAcquisitionsProFormaOtherNonoperatingIncomeExpense	25313	usd
	AIXN	Business Acquisitions Pro Forma Income Tax Expense Benefit BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit	643	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	1947055	usd

Files In Submission

Name	View Source	Status
0001493152-23-040930-index-headers.html	Edgar Link	pending
0001493152-23-040930-index.html	Edgar Link	pending
0001493152-23-040930.txt	Edgar Link	pending
0001493152-23-040930-xbrl.zip	Edgar Link	pending
aixn-20230930.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
aixn-20230930_cal.xml	Edgar Link	unprocessable
aixn-20230930_def.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
aixn-20230930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
aixn-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AIXN
AiXin Life International, Inc. Stock $aixn

2023 Q4 Form 10-Q Financial Statement

#000149315223040930 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIXN AiXin Life International, Inc. Stock $aixn

2023 Q4 Form 10-Q Financial Statement

#000149315223040930 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIXN
AiXin Life International, Inc. Stock $aixn